India Over The Counter Drugs Market PPT 2023: Size, Growth, Demand and Forecast till 2028

1
India Over The Counter (OTC) Drugs Market
Research and Forecast Report 2023-2028




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
India Over The Counter (OTC) Drugs Market
Research Report 2023-2028 According to the
latest report by IMARC Group, titled "India Over
The Counter (OTC) Drugs Market Industry Trends,
Share, Size, Growth, Opportunity and Forecast
2023-2028," the india over the counter (OTC)
drugs market size reached US 7.6 Billion in
2022. Over the counter (OTC) drugs, also known
as non-prescription medicines, are consumed by
individuals without any prescription from a
healthcare professional. These medicines treat
common self-treatable health conditions and
symptoms such as headaches, constipation,
toothache, cold and flu, heartburn, migraines,
menstrual cramps, allergies, dental caries, and
nausea. They are safe for consumption,
cost-effective, easily accessible, convenient,
and time-saving. Over the years, there has been
an escalating demand for OTC drugs in India due
to the growing preference toward self-medication
for minor health problems among
individuals. Request for a PDF sample of this
report https//www.imarcgroup.com/india-over-the-
counter-drugs-market/requestsample

4
Report Description and Highlights
Report Description
India Over The Counter (OTC) Drugs Market
Trends The market is primarily driven by the
rising prevalence of chronic ailments among
individuals across India. In addition, the
growing inclination toward self-medication on
account of high consulting fees charged by
medical professionals is contributing to the
market growth. Moreover, the escalating demand
for OTC drugs to treat analgesics,
gastrointestinal infections, coughs and colds,
musculoskeletal pains, and fever represents
another major growth-inducing factor. Besides
this, the Government of India is taking several
initiatives to make these drugs economical and
accessible, spread awareness, and encourage the
sales of OTC drugs, which is providing a positive
thrust to the market growth. Along with this,
the increasing health awareness among consumers
due to growing lifestyle-related diseases caused
by sedentary lifestyles, poor eating habits,
stress, and obesity is accelerating the product
adoption rate. Apart from this, the increasing
popularity of online pharmacies, the easy
availability of OTC drugs, and continual product
innovations are propelling market growth.
Furthermore, the growing geriatric population,
rising disposable incomes of consumers, and
extensive research and development (RD)
activities conducted by key market players are
also creating a favorable market outlook across
the country.

5
Report Description and Highlights
Report Description
Looking forward, IMARC Group expects the market
value to reach US 19.4 Billion by 2028,
exhibiting a CAGR of 16.7 during the forecast
period (2023-2028). View Report TOC, Figures and
Tables https//www.imarcgroup.com/india-over-the-
counter-drugs-market

6
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Product Type
• Cough, Cold and Flu Products
• Analgesics
• Dermatology Products
• Gastrointestinal Products
• Vitamins, Minerals and Supplements (VMS)
• Weight-loss/Dietary Products
• Ophthalmic Products
• Sleeping Aids
• Others
•  
• Breakup by Route of Administration
• Oral
• Parenteral
• Topical
• Others

7
Report Description and Highlights
Report Description

• Breakup by Dosage Form
• Tablets and Capsules
• Liquids
• Ointments
• Others
•  
• Breakup by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

8
Key Questions Answered in the Report
Report Description

• What was the size of the India over the counter
  (OTC) drugs market in 2022?
• What is the expected growth rate of the India
  over the counter (OTC) drugs market during
  2023-2028?
• What are the key factors driving the India over
  the counter (OTC) drugs market?
• What has been the impact of COVID-19 on the India
  over the counter (OTC) drugs market?
• What is the breakup of the India over the counter
  (OTC) drugs market based on the product type?
• What is the breakup of the India over the counter
  (OTC) drugs market based on route of
  administration?
• What is the breakup of the India over the counter
  (OTC) drugs market based on the dosage form?
• What is the breakup of the India over the counter
  (OTC) drugs market based on the distribution
  channel?
• What are the key regions in the India over the
  counter (OTC) drugs market?
•  

9
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    India Over The Counter (OTC)
Drugs Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

10
Table of Contents
Report Description
6    Market Breakup by Product Type    6.1  
 Cough, Cold and Flu Products        6.1.1
Market Trends        6.1.2 Market Forecast   
6.2    Analgesics        6.2.1 Market Trends   
    6.2.2 Market Forecast    6.3    Dermatology
Products        6.3.1 Market Trends       
6.3.2 Market Forecast    6.4    Gastrointestinal
Products        6.4.1 Market Trends       
6.4.2 Market Forecast    6.5     Vitamins,
Minerals and Supplements (VMS)        6.5.1
Market Trends        6.5.2 Market Forecast     
    Click here to visit the complete table of
content with list of figures and tables
https//www.imarcgroup.com/india-over-the-counter-
drugs-market/toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us
15
(No Transcript)